Pain, psychological variables, sleep quality, and natural killer cell activity in midlife women with and without fibromyalgia

Brain, Behavior, and Immunity

Volumn 18, Issue 4, 2004, Pages 304-313

  Landis, Carol A ^a   Lentz, Martha J ^a   Tsuji, Joyce ^a   Buchwald, Dedra ^a   Shaver, Joan L F ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2 RECEPTOR;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; BLOOD SAMPLING; CELL ACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEPRESSION; DISTRESS SYNDROME; FEMALE; FIBROMYALGIA; HUMAN; INTERVIEW; LYMPHOCYTE; MULTIPLE REGRESSION; NATURAL KILLER CELL; NIGHT; PAIN; PAIN ASSESSMENT; PAIN THRESHOLD; PHENOTYPE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; REGRESSION ANALYSIS; SCORING SYSTEM; SLEEP; STATISTICAL SIGNIFICANCE;

ADULT; AFFECT; AGE FACTORS; DEPRESSION; FEMALE; FIBROMYALGIA; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PAIN; PAIN MEASUREMENT; PITUITARY-ADRENAL SYSTEM; POLYSOMNOGRAPHY; REFERENCE VALUES; SLEEP DISORDERS; STRESS, PSYCHOLOGICAL;

EID: 2442511747     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2003.11.001     Document Type: Article

References (69)

1. Aaron L.A., Buchwald D. A review of the evidence for overlap among unexplained clinical conditions. Annals Intern. Med. 134:2001;868-881
2. Aaron L.A., Bradley L.A., Alarcon G.S., Alexander R.W., Triana-Alexander M., Martin M.Y., Alberts K.R. Psychiatric diagnoses in patients with fibromyalgia are related to health care-seeking behavior rather than to illness. Arthritis Rheum. 39:1996;436-445
3. Affleck G., Urrows S., Tennen H., Higgins P., Abeles M. Sequential daily relations of sleep, pain intensity, and attention to pain among women with fibromyalgia. Pain. 68:1996;363-368
4. American Academy of Sleep Medicine Task Force Report, 1999. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 22, 667-689
5. American Psychiatric Association Diagnostic and Statistical manual of Mental Disorders (3rd ed-revised) DSM-III-R, 1987
6. American Sleep Disorders Association and Sleep Research Society, 1993. Atlas and Scoring Rules: recording and scoring leg movements. Sleep 16, 748-759
7. Aoki T., Miyakoshi H., Usuda Y., Herberman R.B. Short analytical review: low NK syndrome and its relationship to chronic fatigue syndrome. Clin. Immunol. Immunopathol. 69:1993;253-265
8. Arkins S., Dantzer R., Kelley K.W. Somatolactogens, somatomedins, and immunity. J. Dairy Sci. 76:1993;2437-2450
9. Beck A., Ward C., Mendelson M., Moek J., Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry. 4:1961;561-571
10. Beck A., Steer R., Garbin M. Psychometric properties of the Beck depression inventory: 25 years of evaluation. Clin. Psychiatric Rev. 8:1988;77-100
11. Bennett R.M. Disordered growth hormone secretion in fibromyalgia: a review of recent findings and a hypothesized etiology. Z. Rheumatol. 57(Suppl 2):1998;72-76
12. Bennett R.M., Clark S.R., Goldberg L., Nelson D., Bonafede R.D., Porter U., Specht D. Aerobic fitness in the fibrositis syndrome: a controlled study of respiratory gas exchange and Xenon 133 clearance from exercising muscle. Arthritis Rheum. 32:1989;454-460
13. Carette S., Oakson G., Guimont C., Steriade M. Sleep electroencephalography and the clinical response to amitriptyline in patients with fibromyalgia. Arthritis Rheum. 38:1995;1211-1217
14. Cauley J.A., Sandler R.B., Schramm M.A., Kriska A.M., LaPorte R.E. Comparison of methods to measure physical activity in post-menopausal women. Am. J. Clin. Nutrition. 45:1987;14-22
15. Clauw D.J., Chrousos G.P. Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine feaures and potential pathogenic mechanisms. Neuroimmunomodulation. 4:1997;134-153
16. Cohen S., Herbert T.B. Health psychology: psychological factors and physical disease from the perspective of human psychoneuroimmunology. Ann. Rev. Psychol. 47:1996;113-142
17. Derogatis L. SCL-90 Manual. 1977;Johns Hopkins University School of Medicine, Baltimore
18. Dinges D.F., Douglas S.D., Zaugg L., Campbell D.E., McMann J.M., Whitehouse W.G., Carota Orne E., Kapoor S.C., Icaza E., Orne M.T. Leukocytosis and natural killer cell function parallel neurobehavioral fatigue induced by 64. h of sleep deprivation J. Clin. Invest. 93:1994;1930-1939
19. Drewes A.M., Arendt-Nielson L. Pain and sleep in medical diseases: interactions and treatment possibilities, A review. Sleep Res. Online. 4:2001;67-76
20. Ercolani M., Trombini G., Chattat R., Cervini C., Piergiacomi G., Salaffi F., Zeni S., Marcolongo R. Fibromyalgic syndrome: depression and abnormal illness behavior. Multicenter investigation. Psychother. Psychosom. 61:1994;178-186
21. Fujiwara S., Akiyama M., Yamakido M., Seyama T., Kobuke K., Hakoda M., Kyoizumi S., Jones S.L. Cryopreservation of human lymphocytes for assessment of lymphocyte subsets and natural killer cytotoxicity. J. Immun. Methods. 90:1986;265-273
22. Gracely R.H., Petzke F., Wolf J.M., Clauw D.J. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum. 46:2002;1333-1343
23. Granges G., Littlejohn G.O. A comparative study of clinical signs in fibromyalgia/fibrositis syndrome, healthy, and exercising subjects. J. Rheumatol. 20:1993;344-351
24. Heim C., Ehlert U., Hellhammer D.H. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology. 25:2000;1-35
25. Hening W., Allen R., Earley C., Kushida C., Picchietti D., Silber M. The treatment of restless legs syndrome and periodic limb movement disorder. Sleep. 22:1999;970-999
26. Herbert T.B., Cohen S. Depression and immunity: a meta-analytic review. Psych. Bull. 113:1993;472-486
27. Hernanz W., Valenzuela A., Quijada J., Garcia A., Iglesia J., Gutierrez A., Povedano J., Moreno I., Sanchez B. Lymphocyte subpopulations in patients with primary fibromyalgia. J. Rheumatol. 21:1994;2122-2124
28. Hudson J.I., Goldenberg D.L., Pope H.G. Jr., Keck P.E. Jr., Schlesinger L. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am. J. Med. 92:1992;363-367
29. Irwin M., Mascovich A., Gillin J.C., Willoughby R., Pike J., Smith T.L. Partial sleep deprivation reduces natural killer cell activity in humans. Psychosom. Med. 56:1994;493-498
30. Kennedy M., Felson D.T. A prospective long-term study of fibromyalgia syndrome. Arthritis Rheum. 39:1996;682-685
31. Klimas N. Pathogenesis of chronic fatigue syndrome and fibromyalgia. Growth Hormone and IGF Res. 8:1998;123-126
32. Landis C.A., Frey C.A., Lentz M.J., Rothermel J., Buchwald D., Shaver J.L.F. Self-reported sleep quality and fatigue correlates with actigraphy sleep indicators in midlife women with fibromyalgia. Nurs. Res. 52:2003;140-147
33. Landis C.A., Lentz M.J., Tsuji J., Buchwald D., Shaver J.F.L. Natural killer cell function in midlife women with and without fibromyalgia. Comm. Nurs. Res. 35:2002;179
34. Landis C.A., Lentz M.J., Rothermel J., Riffle S.C., Chapman D., Buchwald D., Shaver J.F.L. Decreased nocturnal prolactin and growth hormone in women with fibromyalgia. J. Clin. Endocrinol. Metab. 86:2001;1672-1678
35. Lauer C.J., Pollmacher T. On the issue of drug washout prior to polysomnographic studies in depressed patients. Neuropsychopharmacology. 6:1992;11-16
36. Leal-Cerro A., Povedano J., Astroga R., Gonzalez M., Silva H., Garcia-Pesquera F., Casanueva F.F., Dieguez C. The growth hormone (GH)-releasing hormone-GH-insulin-like growth factor-1 axis in patients with fibromyalgia. J. Clin. Endocrinol. Metab. 84:1999;3378-3381
37. Lentz M.J., Landis C.A., Rothermel J., Shaver J.L.F. Effects of selective slow wave sleep disruption on musculoskeletal pain and fatigue in middle aged women. J. Rheumatol. 26:1999;1586-1592
38. Leventhal L., Freundich B., Lewis J., Gillen K., Henry J., Dinges D. Controlled study of sleep parameters in patients with fibromyalgia. J. Clin. Rheumatol. 1:1995;110-113
39. Lloyd A.R., Wakefield D., Hickie I. Immunity and the pathophysiology of chronic fatigue syndrome. Chronic Fatigue Syndrome, Ciba Foundation Symposium. 173:1993;176-192 Wiley, Chichester
40. Mahowald M.L., Mahowald M.W. Nighttime sleep and daytime functioning (sleepiness and fatigue) in less well-defined chronic rheumatic diseases with particular reference to the 'alpha-delta NREM sleep anomaly'. Sleep Med. 1:2002;195-207
41. Matera L. Action of pituitary and lymphocyte prolactin. Neuroimmunomodulation. 4:1997;170-180
42. McNair, D.M., Lorr, M., Droppleman, L.F., 1971. Profile of Mood States (Manual) TI Educational and Industrial Testing Service, San Diego
43. Moldofsky H. Sleep and fibrositis syndrome. Rheum. Dis. Clin. North Am. 15:1989;91-103
44. Moldfsky H. Sleep, neuroimmune, and neuroendocrine functions in fibromyalgia and chronic fatigue syndrome. Adv. Neuroimmunol. 5:1995;39-56
45. Motzer S.A., Jarrett M., Heitkemper M.M., Tsuji J. Natural killer cell function and psychological distress in women with and without irritable bowel syndrome. Biol. Res. Nurs. 4:2002;31-42
46. Okifuji A., Turk D.C. Stress and psychophysiological dysregulation in patients with fibromyalgia syndrome. Appl. Psychophysiol. Biofeedback. 27:2002;129-141
47. Owens J.F., Mattehws K.A., Wing R.R., Kuller L.H. Physical activity and cardiovascular risk: a cross-sectional study of middle-aged premenopausal women. Preventive Med. 19:1990;147-157
48. Paffenbarger R.S. Jr., Wing A.L., Hyde R.T. Physical activity as an index of heart attack risk in college alumni. Am. J. Epidemiol. 108:1978;161-175
49. Page G.G., Ben-Eliyahu S. The immune-suppressive nature of pain. Semin. Oncol. Nurs. 13:1997;10-15
50. Pillemer S.R., Bradley L.A., Crofford L.J., Moldofsky H., Chrousos G.P. The neuroscience and endocrinology of fibromyalgia. Arthritis Rheum. 40:1997;1928-1939
51. Principe J.C., Smith J.R. SAMICOS-A sleep analyzing microcomputer system. IEEE Trans. Biomed. Engr. 33:1986;935-941
52. Rechtschaffen A., Kales A. A manual of standardized terminology, techniques, and scoring systems for sleep stages in human subjects. 1968;Brain Information Service/Brain Research Institute, UCLA, Los Angeles
53. Russell I.J., Vipraio G.A., Michalek J.E., Craig F.E., Kang Y.K., Richards A.B. Lymphocyte markers and natural killer cell activity in fibromyalgia syndrome: effects of low-dose, sublingual use of human interferon-α J. Inter. Cytokine Res. 19:1999;969-978
54. Sabath D.E., Barcy S., Koelle D.M., Zeh J., Asthon S., Buchwald D. Cellular immunity in monozygotic twins discordant for chronic fatigue syndrome. J. Infect. Dis. 185:2002;828-832
55. Savard J., Laroche L., Simard S., Ivers H., Morin C.M. Chronic insomnia and immune functioning. Psychosom. Med. 65:2003;211-221
56. Shaver J.L.F., Lentz M., Landis C.A., Heitkemper M.M., Buchwald D.S., Woods N.F. Sleep, psychological distress, and stress arousal in women with fibromyalgia. Res. Nurs. Health. 20:1997;247-257
57. Ursin H., Eriksen H.R. Sensitization, subjective health complaints, and sustained arousal. Ann. New York Acad. Sci. 933:2001;119-129
58. Uveges J.M., Parker J.C., Smarr K.L., McGowan J.F., Lyon M.G., Irvin W.S., Meyer A.A., Buckelew S.P., Morgan R.K., Delmonico R.L., Hewett J.E., Kay D.R. Psychological symptoms in primary fibromyalgia syndrome: relationship to pain, life stress, and sleep disturbance. Arthritis Rheum. 33:1990;1279-1283
59. Vedhara K., Fox J.D., Wang E.C.Y. The measurement of stress-related immune dysfunction in psychoneuroimmunology. Neurosci. Biobev. Rev. 23:1999;699-715
60. Vines S.W., Ng A.K., Breggia A., Mahoney R. Multimodal chronic pain rehabilitation program: its effects on immune function, depression, and health behaviors. Rehab. Nurs. 25:2000;185-196
61. Weigent D.A., Bradley L.A., Blalock J.E., Alarcon G.S. Current concepts in the pathophysiology of abnormal pain perception in fibromyalgia. Am. J. Med. Sci. 315:1998;405-412
62. Whiteside T.L., Bryant J., Day R., Herberman R.B. Natural killer cytotoxicity in the diagnosis of immune dysfunction: criteria for a reproducible assay. J. Clin. Lab. Anal. 4:1990;102-114
63. Whiteside T.L., Friberg D. Natural killer cells and natural killer cell activity in chronic fatigue syndrome. Am. J. Med. 105:1998;27S-34S
64. Wolfe F., Anderson J., Harkness D., Bennett R.M., Caro X.J., Goldenberg D.L., Russell I.J., Yunus M.B. Health status and disease severity in fibromyalgia. Arthritis Rheum. 40:1997;1571-1579
65. Wolfe F., Hawley D.J., Wilson K. The prevalence and meaning of fatigue in rheumatic disease. J. Rheumatol. 23:1996;1407-1417
66. Wolfe F., Ross K., Anderson J., Russell I.J., Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 38:1995;19-28
67. Wolfe F., Smythe H., Yunus M., et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum. 33:1990;160-172
68. Yunus M. Towards a model of pathophysiology of fibromyalgia: aberrant central pain mechanisms with peripheral modulation. J. Rheumatol. 19:1992;846-849
69. Yunus M. Psychological aspects of fibromyalgia syndrome: a component of the dysfunctional spectrum syndrome. Masi A. Fibromyalgia and Myofascial Pain Syndromes. 1994;811-837 Bailliere Tindall, London